United States· US:69448-023_4b1ad850-61b1-d516-e063-6394a90aeea8
CAMCEVI
A medicinal product containing leuprolide mesylate, registered in United States by Accord BioPharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LEUPROLIDE MESYLATE
- Manufacturer
- Accord BioPharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 2
- ndc1169448023631 SYRINGE in 1 CARTON (69448-023-63) / .37 g in 1 SYRINGE
- ndc1169448-023-63
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Leuprolide mesylate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCAMCEVI 21 mg suspensie voor injectie met verlengde afgifteAccord Healthcare S.L.U.
- FinlandCAMCEVIAccord Healthcare S.L.U.
- United KingdomCamcevi 42mg prolonged-release suspension for injection pre-filled syringesAccord-UK Ltd
- SwedenCAMCEVI 21 mg Injektionsvätska, depotsuspensionAccord Healthcare S.L.U.
- GermanyEligardRecordati Industria Chimica E Farmaceutica S.P.A.
- IrelandCAMCEVI 21 mg prolonged-release suspension for injectionAccord Healthcare S.L.U.
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
- SpainCAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Eligard Depot, Enantone Monats-Depot
- Belgium · Depo-Eligard
- Bulgaria · Елигард, Лутрат Депо
- Cyprus · Eligard
- Czechia · Eligard, Leptoprol
- Germany · Eligard, Enantone Monats-Depot
- Denmark · Eligard, Leuprorelin Sandoz
- Estonia · Eligard
- Spain · Eligard Semestral, Eligard Trimestral
- Finland · Eligard, Enanton Depot Dual
- France · Eligard, Enantone Lp
- United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
- Greece · Deplanda, Elityran
- Croatia · Eligard, Lerin
- Hungary · Eligard, Leuprorelin Pharmacenter
- Ireland · Eligard, Leuprex 3
- Iceland · Camcevi, Eligard
- Italy · Eligard, Enantone
- Liechtenstein · Camcevi
- Lithuania · Eligard
- Luxembourg · Depo-Eligard, Leugon
- Latvia · Eligard, Leptoprol
- Malta · Deplanda
- Netherlands · Eligard, Leuproreline Sandoz
- Norway · Camcevi, Eligard
- Poland · Eligard, Leuprostin
- Portugal · Eligard, Lutrate Depot
- Romania · Eligard, Leptoprol
- Sweden · Eligard, Enanton Depot Dual
- Slovenia · Eligard, Leptoprol
- Slovakia · Eligard, Leuprorelin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7d8e3c91-38ee-499d-a1e6-8b7d2e44df7c GET /v1/drugs/7d8e3c91-38ee-499d-a1e6-8b7d2e44df7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "42",
"substance": "LEUPROLIDE MESYLATE",
"productndc": "69448-023",
"dosage_form": "INJECTION, EMULSION",
"dea_schedule": null,
"strength_unit": "mg/.37g",
"application_number": "NDA211488",
"marketing_category": "NDA"
}See everything about leuprolide mesylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.